The outline for action includes the following stances:
• AAFP opposes actions action that would limit patient access to pharmaceuticals prescribed by their physicians
• AAFP suggests family physicians individualize and monitor therapy based upon a review of potential risks and benefits
• AAFP supports developing evidence-based provider education for safe and effective use of long-acting and extended-release opioids
• AAFP encourages states to implement prescription drug monitoring programs and interstate exchange of registry information, called for under the National All Schedulers Prescription Electronic Reporting Act of 2005
More Articles on Pain Management:
Pain Specialist Dr. Jack Berndt Joins Pinnacle Pain Center
St. Jude Medcial Recalls Neurostimulation Device for Battery Issues
Ohio Physicians Use Fingerprint Scans to Prevent Painkiller Abuse
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
